. 2021 Jun 2;11:11634. doi: 10.1038/s41598-021-91257-5

Table 3.

Multivariate analysis of primary outcomes among AC, RC, and WC patients receiving IVT.

	WC Reference category	RC OR (95% CI)	AC OR (95% CI)
Three-month dependency^a	1	1.69 (0.66–4.33) p = 0.276	1.64 (0.54–4.97) p = 0.381
Three-month all-cause mortality^a	1	0.81 (0.16–4.08) p = 0.801	6.97 (2.42–20.07) p = 0.001
Presence of SICH^b	1	0.97 (0.96–1.03) p = 0.501	3.66 (0.97–13.69) p = 0.054

WC
Reference category

RC
OR (95% CI)

AC
OR (95% CI)

Three-month dependency^a

1.69 (0.66–4.33)

p = 0.276

1.64 (0.54–4.97)

p = 0.381

Three-month all-cause mortality^a

0.81 (0.16–4.08)

p = 0.801

6.97 (2.42–20.07)

p = 0.001

Presence of SICH^b

0.97 (0.96–1.03)

p = 0.501

3.66 (0.97–13.69)

p = 0.054

OR odds ratios, 95% CI 95% confidence intervals, AC active cancer, RC remote cancer, WC without cancer, ICH intracranial haemorrhage, SICH symptomatic intracranial haemorrhage.

^aAdjusted for age, baseline NIHSS score, and pre-stroke mRS.

^bAdjusted for age, baseline NIHSS score, pre-stroke mRS, and systolic blood pressure.